Structure of 1801530-11-9
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
IKE is a potent, metabolically stable inhibitor of system Xc- and inducer of ferroptosis .
Synonyms: Imidazole Ketone Erastin; PUN30119; IKE
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Kato, Kazuhiro ; Yasui, Hironobu ; Sato-Akaba, Hideo ; Emoto, Miho C ; Fujii, Hirotada G ; Kmiec, Maciej M , et al.
Abstract: Targeting ferroptosis, cell death caused by the iron-dependent accumulation of lipid peroxides, and disruption of the redox balance are promising strategies in cancer therapy owing to the physiological characteristics of cancer cells. However, the detection of ferroptosis using in vivo imaging remains challenging. We previously reported that redox maps showing the reduction power per unit time of implanted tumor tissues via non-invasive redox imaging using a novel, compact, and portable electron paramagnetic resonance imaging (EPRI) device could be compared with tumor tissue sections. This study aimed to apply the EPRI technique to the in vivo detection of ferroptosis. Notably, redox maps reflecting changes in the redox status of tumors induced by the ferroptosis inducing agent imidazole ketone erastin (IKE) were compared with the immunohistochemical images of 4-hydroxynonenal (4-HNE) in tumor tissue sections. Our comparison revealed a negative correlation between the reducing power of tumor tissue and the number of 4-HNE-positive cells. Furthermore, the control and IKE-treated groups exhibited significantly different distributions on the correlation map. Therefore, redox imaging using EPRI may contribute to the non-invasive detection of ferroptosis in vivo.
Show More >
Keywords: Electron paramagnetic ; resonance imaging ; Redox imaging ; tumor redox status ; ferroptosis ; cancer therapy ; Imidazole ketone erastin ; GPX4 ; lipid peroxidation
Show More >
CAS No. : | 1801530-11-9 |
Formula : | C35H35ClN6O5 |
M.W : | 655.14 |
SMILES Code : | O=C1N(C2=CC(C(CN3C=CN=C3)=O)=CC=C2OC(C)C)C(CN4CCN(C(COC5=CC=C(Cl)C=C5)=O)CC4)=NC6=C1C=CC=C6 |
Synonyms : |
Imidazole Ketone Erastin; PUN30119; IKE
|
MDL No. : | MFCD31813799 |
InChI Key : | PSPXJPWGVFNGQI-UHFFFAOYSA-N |
Pubchem ID : | 91824786 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P280-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
HT1080 cells | 2 μM | 10-14 hours | To study IKE-induced lipid peroxidation and cell death, results showed that IKE significantly increased ROS accumulation and cell death. | PMC11487270 |
HT-1080 | 150 nM | 12 hours | To evaluate erastin2-induced ferroptosis, results showed HT-1080 cells were sensitive to erastin2, with accumulation of lipid peroxides and decreased cell confluence. | PMC11700874 |
H460 | 150 nM | 12 hours | To evaluate erastin2-induced ferroptosis, results showed H460 cells were resistant to erastin2, with no significant accumulation of lipid peroxides or decrease in cell confluence. | PMC11700874 |
C6 | 150 nM | 12 hours | To evaluate erastin2-induced ferroptosis, results showed C6 cells were highly sensitive to erastin2, with significant accumulation of lipid peroxides and decreased cell confluence. | PMC11700874 |
Rheumatoid arthritis synovial fibroblasts (RASFs) | 1 μM | 18 hours | To evaluate the ferroptosis-inducing effect of IKE on synovial fibroblasts, results showed that IKE significantly increased lipid ROS accumulation. | PMC8813949 |
LLC mouse lung carcinoma cell line | 5 μM | 24 hours | MI-EXO suppressed erastin-induced lipid-ROS accumulation and ferroptosis | PMC10040407 |
K7M2 mouse osteosarcoma cell line | 20 μM | 24 hours | MI-EXO suppressed erastin-induced lipid-ROS accumulation and ferroptosis | PMC10040407 |
NTC/T1 null cells | 50 μM | 24 hours | To evaluate the inhibitory effect of IKE on the growth of LSCC organoids, it was found that ERO1α depletion significantly enhanced the inhibitory effect of IKE. | PMC11015652 |
OS-RC-2 cells | 2 μM | 24-30 hours | To study IKE-induced lipid peroxidation and cell death, results showed that IKE significantly increased ROS accumulation and cell death. | PMC11487270 |
HT-1080 cells | 0.5 μM | 4 hours | To study the mechanism of RSL3-induced ferroptosis | PMC9809962 |
Calu-1 cells | 0.5 μM | 4 hours | To study the mechanism of RSL3-induced ferroptosis | PMC9809962 |
HepG2 cells | 10 μM | 4 hours | Measure the level of ferroptosis and analyze the expression of RB1CC1 and related proteins | PMC8882240 |
A549 cells | 1 μM | 4 hours | Evaluate the effect of drugs on stimulating RB1CC1 nuclear translocation | PMC8882240 |
T24 cells | 2 μM | 48 hours | USP52-depleted T24 cells exhibited heightened sensitivity to Erastin-induced ferroptosis | PMC11615784 |
HEK293T cells | 25 nM | 60 hours | Identified USP52 as a key regulator of xCT protein levels | PMC11615784 |
LLC | 20 μM | To evaluate the inhibitory effect of IKE on LLC cell activity, the results showed that cell viability was reduced to 45% at 20 μM concentration. | PMC10754143 | |
A549 | 20 μM | To evaluate the inhibitory effect of IKE on A549 cell activity, the results showed that cell viability was reduced to 52% at 20 μM concentration. | PMC10754143 | |
H1299 | 20 μM | To evaluate the inhibitory effect of IKE on H1299 cell activity, the results showed that cell viability was reduced to 52% at 20 μM concentration. | PMC10754143 | |
GBM cells | 5 µM | GBM cells exhibit high resistance to IKE-induced ferroptosis, but co-treatment with IKE and DHAA significantly enhances their sensitivity. | PMC10522586 | |
PCa cells | 2 µM | PCa cells exhibit high resistance to IKE-induced ferroptosis, but co-treatment with IKE and DHAA significantly enhances their sensitivity. | PMC10522586 | |
Human aortic smooth muscle cells (HASMCs) | 2 μM | IKE induced ferroptosis in HASMCs, and overexpression of METTL3 accelerated IKE-induced ferroptosis, while knockdown of METTL3 inhibited IKE-induced ferroptosis. | PMC9274489 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Mouse | Xenograft tumor model | 30 mg/kg | Not used | MI significantly reduced the sensitivity of tumors to erastin or IKE-induced ferroptosis | PMC10040407 | |
Nude mice | OS-RC-2 tumor model | intraperitoneal injection | 40 mg/kg | every other day for 12 days | To study the inhibitory effect of IKE on tumor growth, results showed that IKE significantly inhibited tumor growth, and the effect was enhanced when combined with SAM. | PMC11487270 |
DBA/1 mice | Collagen-induced arthritis (CIA) model | Intraperitoneal injection | 40 mg/kg | Once daily for 22 days | To evaluate the alleviating effect of IKE on joint inflammation and destruction in CIA model mice, results showed that IKE significantly reduced synovial inflammation and accelerated inflammation resolution. | PMC8813949 |
Nude mice | HT-1080 cell xenograft model | Intraperitoneal injection | 40 mg/kg | Once every other day for 2 weeks | To evaluate the tumor suppression effect of IKE | PMC9809962 |
BALB/c Nude mice | Bladder cancer xenograft model | Intraperitoneal injection | 40 mg/kg | Every other day for two weeks | Combination of USP52 depletion and IKE treatment significantly inhibited bladder cancer progression | PMC11615784 |
Nude mice | LSCC PDX model | Intraperitoneal injection | 40 mg/kg | Once every other day, continuous treatment | To evaluate the inhibitory effect of combined ERO1α inhibition and IKE treatment on PDX tumor growth, it was found that the combined treatment significantly suppressed tumor growth. | PMC11015652 |
rats | C6 glioma model | intravenous injection | 25 mg/kg | single dose, lasting 30 minutes | To evaluate the inhibition of system xc- by IKE in the C6 glioma model, results showed IKE significantly reduced [18F]hGTS13 uptake, indicating effective inhibition of system xc-. | PMC11700874 |
C57BL/6 mice | LLC-luc lung cancer model | IntratumOral injection | 50 mg/kg | Every three days, for a total of three injections | To evaluate the efficacy of IKE combined with PDT in the LLC-luc lung cancer model, the results showed that the combination treatment significantly inhibited tumor growth, with an average tumor volume reduction of 88.0%. | PMC10754143 |
C57BL/6J mice | glioblastoma xenograft model | intracerebroventricular injection | 650 ng | daily for 7 days | Co-treatment with IKE and DHAA significantly reduced tumor size and prevented tumor invasion and migration, demonstrating its efficacy in inducing ferroptosis in vivo. | PMC10522586 |
Mice | BAPN-induced aortic dissection model | Intraperitoneal injection | 5 mg/kg | Once every 2 days in the first week and once a day in the second and third weeks, lasting for 3 weeks | Liproxstatin-1 significantly reduced the incidence and mortality of BAPN-induced aortic dissection and alleviated aortic degeneration. | PMC9274489 |
BALB/c Nude mice | ZR-75-1-TamR xenograft model | Intraperitoneal injection | 40 mg/kg | Every three days until the end of the experiment | IKE in combination with Tamoxifen significantly inhibited the growth of ZR-75-1-TamR tumors and reduced the levels of SLC7A11 and Ki67 in tumor tissues, while increasing the levels of 4-HNE. | PMC11756422 |
C57BL/6 mice | hypercholesterolemic mice induced by high-cholesterol diet (HCD) | intraperitoneal injection | 40 mg/kg | every other day for 1 month | To evaluate the effect of IKE on ferroptosis sensitivity of HSCs in hypercholesterolemic mice, the results showed that IKE significantly restored the maintenance and differentiation balance of HSCs. | PMC10025135 |
Mice | cell-derived xenograft (CDX) mouse models | daily administration | 50 mg/kg | daily administration until the end of the experiment | Evaluate the inhibitory effect of IKE on tumor growth | PMC8882240 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.53mL 0.31mL 0.15mL |
7.63mL 1.53mL 0.76mL |
15.26mL 3.05mL 1.53mL |
Tags: Imidazole ketone erastin | IKE | IKE (Imidazole ketone erastin ) | PUN30119 | PUN 30119 | PUN-30119 | cystine-glutamate antiporter | ferroptosis activator | ferroptosis | 1801530-11-9
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL